Allergy & Immunology

Myeloproliferative Neoplasms

Questions discussed in this category

How do you think about using Ropeginterferon Alfa 2B for polycythemia vera in patients with active autoimmune disease?

Would you consider this an absolute contraindication? What if the autoimmune disease was stable and not active?

1 Answer available

Papers discussed in this category

Lancet Haematol, 2020 Jan 31

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.

Related Topics in Allergy & Immunology